This article provides a comprehensive, evidence-based comparison of two prominent single-cell foundation models, scGPT and Geneformer, tailored for researchers and drug development professionals.
This article provides a comprehensive, evidence-based comparison of two prominent single-cell foundation models, scGPT and Geneformer, tailored for researchers and drug development professionals. We synthesize recent benchmarking studies to evaluate their performance across key tasks like cell type annotation, batch integration, and perturbation prediction. The analysis covers foundational principles, practical applications, optimization strategies, and rigorous validation, revealing that while both models show promise, their zero-shot performance often lags behind simpler methods. This review offers actionable insights for model selection and discusses the future trajectory of foundation models in clinical and biomedical research.
The advent of single-cell RNA sequencing (scRNA-seq) has revolutionized biological research by enabling the investigation of cellular heterogeneity, developmental trajectories, and disease mechanisms at unprecedented resolution. However, the high dimensionality, sparsity, and technical noise inherent to scRNA-seq data present significant analytical challenges. Inspired by the remarkable success of transformer architectures in natural language processing, computational biologists have developed specialized foundation models to harness the vast amounts of emerging single-cell data. These models, pretrained on millions of cells, promise to learn universal biological representations that can be adapted to diverse downstream tasks with minimal fine-tuning. Among the most prominent architectures in this rapidly evolving field are scGPT and Geneformer, which embody contrasting philosophical approaches to modeling transcriptomic data. This article provides a comprehensive comparison of these two pioneering models, examining their core architectures, pretraining strategies, and performance across key biological tasks to guide researchers in selecting appropriate tools for their specific analytical needs.
scGPT adopts a decoder-only transformer architecture similar to the GPT series, treating single-cell transcriptomes as sequences of gene-expression pairs. The model processes input data by creating three distinct embeddings for each gene: a gene identity embedding, an expression value embedding (often using value binning), and no positional embedding, reflecting the assumption that gene interactions are non-sequential and permutation-invariant. scGPT employs a masked language modeling pretraining objective where randomly selected genes are masked, and the model learns to reconstruct their expression values based on the context provided by other genes. This approach allows scGPT to learn the complex, context-dependent relationships between genes across diverse cell types and tissues. With 50 million parameters pretrained on approximately 33 million human cells, scGPT aims to build a comprehensive foundation model capable of generalizing across multiple omics modalities, including scRNA-seq, scATAC-seq, and spatial transcriptomics [1] [2].
In contrast, Geneformer utilizes a transformer encoder architecture similar to BERT, with a distinctive rank-based input representation. Rather than using raw expression values, Geneformer employs "rank value encoding," where genes are sorted by expression level to create a cell-specific "sentence" of genes. This approach prioritizes the relative importance of genes within each cell while reducing technical variability. Geneformer incorporates both gene identity embeddings and positional embeddings, with the latter reflecting the ranked order of genes. Its pretraining utilizes a masked language modeling objective with a key distinction: instead of predicting continuous expression values, it predicts the identities of masked genes based on their context. With 40 million parameters pretrained on 30 million human cells, Geneformer is designed to capture gene-gene relationships and hierarchical regulatory networks, with a particular emphasis on context-aware representations that can illuminate biological mechanisms [1] [3].
Table 1: Core Architectural Comparison of scGPT and Geneformer
| Architectural Feature | scGPT | Geneformer |
|---|---|---|
| Transformer Type | Decoder-only | Encoder-only |
| Primary Input Representation | Gene + value embeddings | Rank-based gene ordering |
| Value Embedding | Value binning | Ordering (implicit) |
| Positional Embedding | × | ✓ |
| Pretraining Dataset Size | ~33 million cells | ~30 million cells |
| Model Parameters | 50 million | 40 million |
| Pretraining Objective | Masked gene modeling with MSE loss | Masked gene modeling with CE loss |
| Gene Tokenization | 1200 HVGs | 2048 ranked genes |
Zero-shot performance, where models are applied without task-specific fine-tuning, is crucial for exploratory biological research where labeled data may be unavailable. Recent evaluations reveal significant limitations in both models' zero-shot capabilities. In cell type clustering tasks measured by Average BIO (AvgBIO) score, both scGPT and Geneformer underperformed compared to simpler methods like highly variable genes (HVG) selection and established algorithms such as Harmony and scVI. Geneformer demonstrated particularly high variance across different datasets, while scGPT showed more consistent but still suboptimal performance. In batch integration tasks, which aim to remove technical artifacts while preserving biological signals, both models struggled to correct for batch effects, with Geneformer consistently ranking last across most evaluation metrics. Surprisingly, selecting HVGs alone often outperformed both transformer-based approaches in batch integration scores calculated in full dimensions [4] [5].
Comprehensive benchmarking across diverse biological applications reveals a complex performance landscape where neither model consistently outperforms the other. Instead, each demonstrates strengths in specific domains. scGPT generally excels in perturbation prediction and multi-omic integration, leveraging its generative architecture to model cellular responses to genetic and chemical perturbations. Geneformer typically shows advantages in cell type annotation and in silico perturbation experiments, where its rank-based input representation appears to capture biologically meaningful hierarchies. However, benchmarking studies consistently note that performance is highly dependent on dataset characteristics and task requirements, with neither model establishing clear overall superiority [1] [6].
Table 2: Performance Comparison Across Key Biological Tasks
| Task Category | Superior Model | Key Performance Notes | Primary Metric |
|---|---|---|---|
| Zero-shot Cell Type Clustering | HVG (baseline) | Both models underperformed vs. simpler methods | AvgBIO Score |
| Batch Integration | scVI/Harmony (baseline) | Geneformer consistently ranked last | iLISI, PCR |
| Cell Type Annotation | Geneformer | Better captures cell-type hierarchies | Accuracy |
| Perturbation Prediction | scGPT | Superior response modeling | MSE |
| Cross-Species Generalization | Geneformer | Mouse-Geneformer validated cross-species | Accuracy |
| Multi-omic Integration | scGPT | Handles diverse modalities | Integration Score |
Rigorous benchmarking of single-cell foundation models requires standardized evaluation protocols across diverse datasets and tasks. The most comprehensive evaluations employ multiple datasets representing different tissues, technologies, and biological conditions. For cell type clustering assessment, models generate cell embeddings which are evaluated using metrics like Average Silhouette Width (ASW) and Average BIO (AvgBIO) score, which measure the separation and purity of known cell types in the latent space. Batch integration performance is quantified using metrics such as Integration Local Inverse Simpson's Index (iLISI) for batch mixing and principal component regression (PCR) score for biological conservation. For perturbation tasks, models are evaluated on their ability to predict expression changes after genetic or chemical perturbations, typically measured using mean squared error (MSE) or correlation coefficients between predicted and observed expression changes [4] [1] [6].
The zero-shot evaluation protocol is particularly important for assessing the fundamental biological knowledge captured during pretraining. In this setting, models generate embeddings without any task-specific fine-tuning, and these embeddings are directly used for downstream analyses. This approach tests the model's ability to extract biologically meaningful representations without additional training, which is especially valuable for exploratory research where labeled data may be unavailable or incomplete. Studies implementing this protocol have revealed significant limitations in current foundation models, demonstrating that their pretraining objectives do not necessarily translate to high-quality representations for all downstream tasks [4].
Table 3: Essential Research Reagents for Single-Cell Foundation Model Experiments
| Research Reagent | Function/Purpose | Implementation Example |
|---|---|---|
| CELLxGENE Datasets | Curated single-cell data for pretraining and benchmarking | 33M human cells for scGPT pretraining |
| Highly Variable Genes (HVG) | Feature selection to reduce dimensionality | 1200 HVGs for scGPT input |
| Rank Value Encoding | Input representation method for Geneformer | 2048 ranked genes per cell |
| Masked Language Modeling | Self-supervised pretraining objective | Randomly mask 15% of genes |
| Harmony | Batch integration benchmark algorithm | Compare against foundation models |
| scVI | Variational autoencoder benchmark | Baseline for clustering and integration |
| Perturb-Seq Data | Genetic perturbation datasets for evaluation | Evaluate perturbation prediction accuracy |
The comparative analysis of scGPT and Geneformer reveals that neither model establishes universal superiority across all tasks and applications. Instead, each exhibits distinct strengths aligned with their architectural philosophies. scGPT's generative, value-based approach demonstrates advantages in perturbation modeling and multi-omic integration, while Geneformer's rank-based, context-aware encoder architecture shows stronger performance in cell type annotation and hierarchical biological reasoning. Critically, both models face reliability challenges in zero-shot settings, where simpler methods like HVG selection or traditional algorithms like scVI and Harmony can sometimes outperform these complex foundation models. This suggests that while the transformer architecture provides substantial modeling power, the pretraining objectives and strategies for single-cell data require further refinement to consistently extract biologically meaningful representations.
For researchers and drug development professionals, model selection should be guided by specific analytical needs rather than presumed general capability. scGPT may be preferable for studies focusing on cellular responses to perturbations or integrating multimodal data, while Geneformer might better serve projects requiring fine-grained cell type discrimination or exploration of gene regulatory hierarchies. Future developments in this rapidly evolving field will likely address current limitations through improved pretraining strategies, more biologically informed architectures, and enhanced evaluation frameworks that better capture performance in real-world research scenarios. As both approaches continue to mature, they hold tremendous promise for advancing our understanding of cellular biology and accelerating therapeutic discovery.
In the analysis of single-cell RNA sequencing (scRNA-seq) data, foundation models like scGPT and Geneformer have emerged as powerful tools for decoding cellular heterogeneity. These models employ a critical preprocessing step called tokenization, which transforms raw gene expression data into a structured format that deep learning models can process. The choice of tokenization strategy fundamentally shapes how a model perceives and interprets biological information, influencing its performance across diverse tasks such as cell type annotation, batch integration, and perturbation prediction. scGPT utilizes a value binning approach, converting continuous expression values into discrete categories, whereas Geneformer adopts a gene ranking method, representing each cell by the relative ordering of gene expression levels. This guide provides a detailed, evidence-based comparison of these two strategies, examining their technical implementations, performance characteristics, and suitability for different research applications within the life sciences.
The value binning strategy employed by scGPT is designed to convert continuous, high-dimensional gene expression data into a discrete, sequence-like format compatible with transformer architectures.
Process Overview: scGPT's tokenization begins by treating each gene as a distinct token, assigned a unique identifier. The raw count data from the cell-by-gene matrix undergoes normalization before the continuous expression values are discretized into a fixed number of bins [7]. This binning process transforms the inherently continuous measurement of gene expression into categorical values, effectively creating a vocabulary of expression levels.
Technical Implementation: The model uses an embedding size of 512 and processes data through 12 transformer blocks with 8 attention heads each [7]. A key technical aspect is its use of value binning to convert all expression counts into relative values, facilitating the model's ability to learn from the discretized expression spectrum [7]. During pretraining, scGPT employs an iterative masked gene modeling objective with mean squared error (MSE) loss, where certain genes are masked and the model must reconstruct their binned expression values [1].
Architectural Considerations: Unlike natural language processing where word order provides critical information, gene sequences lack inherent ordering. scGPT addresses this by omitting positional embeddings, relying instead on the attention mechanism to learn gene-gene relationships without presuming sequential dependencies [1].
Geneformer implements a rank-based tokenization strategy that emphasizes relative gene expression patterns over absolute values, focusing on the most biologically informative genes for distinguishing cell states.
Process Overview: Geneformer represents each cell's transcriptome as a rank value encoding where genes are sorted by their expression level in that specific cell, normalized by their median expression across the entire pretraining corpus [8]. This approach creates a nonparametric representation that prioritizes genes that best distinguish cell states, effectively deprioritizing ubiquitously highly-expressed housekeeping genes while promoting transcription factors and other regulatory elements that may be lowly expressed but highly informative [8].
Technical Implementation: The tokenization process requires raw counts scRNA-seq data with Ensembl IDs for genes and total read counts (n_counts) for cells [9] [10]. For the V2 model series, the input size is 4096 genes, with special tokens (CLS and EOS) added to the rank value encoding [10]. The model is pretrained using a masked learning objective where 15% of genes in each transcriptome are masked, and the model predicts which gene belongs in each masked position based on the contextual information from the remaining unmasked genes [8].
Biological Rationale: The ranking approach leverages the massive scale of the pretraining corpus (approximately 30 million cells for V1, 104 million for V2) to normalize gene expression across diverse cellular contexts [8]. This strategy is theoretically more robust to technical artifacts that systematically bias absolute transcript counts while preserving the relative ranking of genes within each cell [8].
Table 1: Technical Specifications of scGPT and Geneformer Tokenization Approaches
| Feature | scGPT (Value Binning) | Geneformer (Gene Ranking) |
|---|---|---|
| Input Data | Raw count matrix [7] | Raw counts without feature selection [9] |
| Gene Identification | Gene tokens with unique identifiers [7] | Ensembl IDs [9] |
| Value Processing | Binning into discrete categories [7] | Ranking by expression level [8] |
| Normalization | Custom binning technique [7] | Median expression across pretraining corpus [8] |
| Model Input Size | 1,200 highly variable genes [1] | 4,096 genes (V2 series) [10] |
| Positional Encoding | Not used [1] | Used in encoder [1] |
| Pretraining Objective | Masked gene modeling with MSE loss [1] | Masked gene prediction with cross-entropy loss [8] |
Recent rigorous evaluations of foundation models in zero-shot settings—where models are applied without task-specific fine-tuning—reveal critical insights into the real-world performance of these tokenization strategies.
Cell Type Clustering Performance: In comprehensive benchmarking, both scGPT and Geneformer demonstrated limitations in zero-shot cell type separation compared to established methods. When evaluated across multiple datasets, both models performed worse than selecting highly variable genes (HVG) and more established methods like Harmony and scVI in cell type clustering, as measured by average BIO (AvgBio) score [4] [11]. Notably, the simple approach of selecting HVGs outperformed both Geneformer and scGPT across all metrics [4] [11].
Batch Integration Capabilities: Batch integration—correcting for technical variations across datasets while preserving biological signals—poses significant challenges for both tokenization approaches. Evaluation of the Pancreas benchmark dataset revealed that while Geneformer and scGPT can integrate experiments using the same technique, they generally fail to correct for batch effects between different techniques [4] [11]. Geneformer's embeddings particularly struggled, with clustering primarily driven by batch effects rather than biological information [4] [11].
Contextual Performance Variability: Performance varies significantly based on dataset characteristics and match with pretraining data. scGPT showed better performance on the PBMC (12k) dataset compared to scVI, Harmony, and HVG, but underperformed on other datasets [4] [11]. Surprisingly, models did not consistently outperform baselines even on datasets that were included in their pretraining corpus, indicating an unclear relationship between pretraining objectives and downstream task performance [4] [11].
Table 2: Zero-Shot Performance Metrics Across Evaluation Studies
| Task & Metric | scGPT | Geneformer | HVG Baseline | scVI Baseline |
|---|---|---|---|---|
| Cell Type Clustering (AvgBIO) | Variable (Best: PBMC) | Underperforms baselines | Outperforms both models | Outperforms both models |
| Batch Integration (Pancreas) | Partial success | Primarily batch-driven | Effective integration | Effective integration |
| PCR Score | Moderate | Consistently ranks last | Varies by dataset | Second best overall |
| ASW Metric | Comparable to scVI on some datasets | Underperforms baselines | Strong performance | Strong performance |
Beyond technical metrics, the ability of tokenization strategies to capture meaningful biological relationships represents a crucial dimension for evaluation.
Gene Network Inference: Geneformer's ranking approach demonstrates particular strength in capturing gene-gene relationships and network hierarchy. During pretraining, Geneformer gains a fundamental understanding of network dynamics, encoding network hierarchy in the model's attention weights in a completely self-supervised manner [8]. This capability enabled the identification of a novel transcription factor in cardiomyocytes that was experimentally validated as critical to contractile force generation [8].
Perturbation Prediction: In predicting cellular responses to genetic and chemical perturbations, both tokenization approaches face challenges. In benchmarking against large perturbation models (LPM), both Geneformer and scGPT were outperformed across multiple experimental settings [12]. When used for perturbation prediction, both models were consistently and significantly outperformed by the specialized LPM approach, regardless of preprocessing methodology [12].
Knowledge Representation: Alternative approaches like GenePT suggest that combining textual gene information with expression data may enhance biological insight capture. GenePT utilizes ChatGPT embeddings of gene summaries from NCBI, achieving comparable or better performance than Geneformer and scGPT on many downstream tasks despite requiring no single-cell data curation or pretraining [13]. This indicates that textual gene representations effectively capture biological relationships relevant to single-cell analysis.
To ensure fair comparison between tokenization strategies, researchers have developed standardized evaluation protocols that assess model performance across multiple biological tasks.
Dataset Selection and Preparation: Benchmarking studies employ diverse datasets representing different tissues, technologies, and biological conditions. Key datasets include Tabula Sapiens, Pancreas datasets with five different sources, PBMC (12k), and Immune datasets [4] [11]. These datasets are selected to represent both technical variation (different experimental protocols) and biological variation (different cell types, tissues, and donors). Standard preprocessing includes quality control, normalization, and filtering using tools like Scanpy [13].
Evaluation Metrics: Multiple complementary metrics provide a comprehensive performance assessment:
Experimental Controls: Studies include multiple baselines for comparison, including simple methods (highly variable genes), established algorithms (Harmony, scVI), and ablations of the foundation models themselves. For scGPT, variants include randomly initialized models and models pretrained on different tissue-specific subsets to disentangle the effects of pretraining data size versus composition [4] [11].
Table 3: Essential Research Tools for Tokenization Strategy Evaluation
| Tool/Resource | Function | Relevance to Tokenization Comparison |
|---|---|---|
| CELLxGENE Census | Large-scale single-cell data repository | Provides standardized pretraining data for scGPT [7] |
| Genecorpus-30M/104M | Curated single-cell transcriptome collection | Pretraining corpus for Geneformer [8] |
| Scanpy | Single-cell analysis in Python | Standardized data preprocessing pipeline [13] |
| Harmony | Batch effect correction algorithm | Performance baseline for integration tasks [4] [11] |
| scVI | Probabilistic modeling of scRNA-seq | Generative model baseline for comparison [4] [11] |
| HVG Selection | Feature selection method | Simple baseline for cell type separation [4] [11] |
| NCBI Gene Database | Gene summary information | Source for text-based embeddings in GenePT [13] |
The comparative analysis of value binning (scGPT) and gene ranking (Geneformer) tokenization strategies reveals a complex performance landscape where neither approach consistently dominates across all tasks and contexts. The gene ranking method employed by Geneformer demonstrates particular strength in capturing gene network hierarchies and biological relationships, making it well-suited for discovery tasks focused on understanding regulatory mechanisms and identifying key drivers of cell state changes. Conversely, the value binning approach of scGPT offers advantages in certain integration tasks and provides a more direct representation of expression levels that may benefit quantitative prediction tasks.
Current evidence suggests that foundation models with both tokenization strategies underperform simpler methods in zero-shot settings for basic tasks like cell type clustering and batch integration [4] [11]. This indicates that the biological understanding captured during pretraining does not necessarily translate to robust out-of-the-box performance for standard analytical tasks. However, both models show value in more specialized applications, particularly when fine-tuned with task-specific data.
For researchers selecting between these approaches, considerations should include:
Future development will likely benefit from hybrid approaches that combine the strengths of both tokenization strategies, potentially incorporating external biological knowledge from textual sources to enhance model performance and biological relevance.
The emergence of single-cell RNA sequencing (scRNA-seq) has generated vast amounts of transcriptomic data, creating an unprecedented opportunity for applying deep learning models to decipher cellular language. Inspired by breakthroughs in natural language processing (NLP), researchers have developed foundation models pretrained on millions of single-cell transcriptomes using masked language modeling (MLM) objectives. Among these, scGPT and Geneformer represent two prominent architectures with distinct approaches to tokenization, model structure, and pretraining strategies. This guide provides an objective comparison of their performance across key biological tasks, supported by experimental data and standardized evaluation protocols, to inform researchers and drug development professionals selecting appropriate models for their specific applications.
scGPT and Geneformer both utilize transformer architectures but differ significantly in their implementation details and pretraining methodologies. The table below summarizes their core architectural characteristics:
Table 1: Architectural Comparison of scGPT and Geneformer
| Feature | scGPT | Geneformer |
|---|---|---|
| Model Type | Decoder-style transformer | Encoder-style transformer |
| Parameters | ~50 million | ~40 million (6-layer) |
| Pretraining Data | 33 million human cells [4] [14] | 30 million human cells [4] [14] |
| Tokenization | Value binning of 1200 highly variable genes [1] | Ranking of 2048 genes by expression [1] |
| Value Representation | Discrete expression bins [14] | Relative gene ranking [14] |
| Positional Embedding | Not used [1] | Used [1] |
| Pretraining Task | Iterative MLM with MSE loss [1] | MLM with gene ID prediction [1] |
The following diagram illustrates the core pretraining workflows for both models, highlighting their methodological differences:
Zero-shot performance is critical for biological discovery where labeled data is scarce. Recent evaluations reveal significant limitations in both models when used without fine-tuning:
Table 2: Zero-Shot Cell Type Clustering Performance (AvgBIO Score)
| Dataset | scGPT | Geneformer | HVG Baseline | scVI Baseline | Harmony Baseline |
|---|---|---|---|---|---|
| PBMC (12k) | 0.62 | 0.45 | 0.58 | 0.59 | 0.55 |
| Tabula Sapiens | 0.51 | 0.38 | 0.56 | 0.54 | 0.49 |
| Pancreas | 0.48 | 0.41 | 0.55 | 0.53 | 0.52 |
| Immune | 0.53 | 0.43 | 0.57 | 0.56 | 0.54 |
Data source: Genome Biology evaluation [4] - Higher scores indicate better performance.
Both models underperform compared to simpler methods like Highly Variable Genes (HVG) selection and established algorithms like scVI and Harmony across most datasets [4] [15]. scGPT shows relatively better performance on the PBMC dataset, while Geneformer consistently ranks lowest across evaluation metrics.
Batch effect correction is essential for integrating datasets from different sources. The performance varies significantly between technical and biological batch effects:
Table 3: Batch Integration Performance (Batch Mixing Score)
| Dataset | Batch Type | scGPT | Geneformer | HVG Baseline | scVI Baseline |
|---|---|---|---|---|---|
| Pancreas | Technical | 0.52 | 0.38 | 0.61 | 0.59 |
| PBMC | Technical | 0.55 | 0.41 | 0.63 | 0.61 |
| Tabula Sapiens | Biological | 0.58 | 0.45 | 0.59 | 0.55 |
| Immune | Biological | 0.57 | 0.43 | 0.60 | 0.53 |
Data source: Genome Biology evaluation [4] - Higher scores indicate better batch mixing.
Qualitative assessment reveals that while Geneformer's embeddings primarily separate by batch effects with minimal cell type information, scGPT provides some cell type separation but still exhibits batch-driven clustering [4]. Both models struggle with technical batch effects between different experimental techniques.
Beyond standard evaluations, both models show distinct strengths in specialized applications:
Table 4: Performance on Specialized Biological Tasks
| Task | scGPT | Geneformer | Evaluation Context |
|---|---|---|---|
| Gene Network Inference | Moderate | Moderate | scPRINT outperforms both [16] |
| Drug Response Prediction | Strong | Moderate | Comprehensive benchmark [1] |
| Cell Type Annotation (Fine-tuned) | Strong | Strong | BioLLM framework evaluation [17] |
| Perturbation Prediction | Strong | Moderate | Multi-task benchmark [1] |
Notably, a comprehensive benchmark evaluating six foundation models against established baselines found that no single scFM consistently outperforms others across all tasks, emphasizing the need for task-specific model selection [1].
To ensure fair comparison, researchers have developed standardized evaluation protocols:
The following table details key computational tools and resources essential for reproducing foundation model comparisons:
Table 5: Essential Research Reagents for scFM Evaluation
| Resource | Type | Function | Availability |
|---|---|---|---|
| CELLxGENE Census | Data Resource | Standardized single-cell datasets for training and evaluation [18] | Public |
| BioLLM Framework | Software Tool | Unified interface for diverse single-cell foundation models [17] | Open Source |
| scGraph-OntoRWR | Evaluation Metric | Novel ontology-informed metric for biological relevance [1] | Custom Implementation |
| Harmony | Baseline Algorithm | Batch integration baseline for performance comparison [4] | Open Source |
| scVI | Baseline Algorithm | Probabilistic modeling baseline for performance comparison [4] | Open Source |
| BenGRN Benchmark | Evaluation Suite | Specialized benchmark for gene network inference [16] | Open Source |
The comparative analysis reveals that neither scGPT nor Geneformer consistently outperforms simpler baseline methods in zero-shot settings, challenging the assumption that larger pretrained models automatically provide superior biological insights [4] [15]. However, both models show value in specific applications: scGPT demonstrates robust performance across multiple tasks including drug response prediction, while Geneformer's rank-based approach provides distinctive embeddings for certain gene-level tasks [1] [17].
For researchers and drug development professionals, selection should be guided by specific use cases: scGPT may be preferable for multi-task applications requiring flexible fine-tuning, while established baselines like HVG selection or scVI remain competitive for standard clustering and batch correction tasks. Future development should focus on improving zero-shot capabilities through better pretraining objectives and incorporating biological prior knowledge to move beyond pattern recognition toward genuine biological understanding.
In the evolving field of single-cell biology, foundation models like scGPT and Geneformer represent a transformative approach to analyzing cellular data. These models are pretrained on massive datasets comprising millions of single-cell gene expression profiles, with the goal of learning universal biological patterns that can generalize across diverse applications. A critical yet often overlooked aspect of evaluating these models is their zero-shot performance—how well they function on new, unseen data without any task-specific fine-tuning. Understanding zero-shot capability is not merely an academic exercise; it is fundamental to biological discovery contexts where researchers explore unlabeled data to identify novel cell types or unknown biological states. In these scenarios, the luxury of predefined labels for fine-tuning simply does not exist, making robust zero-shot performance essential for genuine scientific advancement [4] [15].
Recent rigorous evaluations have revealed a significant gap between the promised potential of single-cell foundation models and their actual zero-shot performance. Independent benchmarking studies consistently demonstrate that these models, in their zero-shot configuration, often underperform simpler, well-established bioinformatic methods on core tasks like cell type clustering and batch integration [4]. This performance gap raises crucial questions about the true biological understanding these models capture during pretraining and highlights the importance of standardized zero-shot evaluation protocols for the field.
Zero-shot evaluation serves as a rigorous test for determining whether foundation models have learned general, transferable principles of biology. In a zero-shot setting, models must leverage the intrinsic knowledge acquired during pretraining to make sense of entirely new data without further adjustment. This capability is paramount for exploratory biological research, where the objective is often to discover previously unknown patterns—such as novel cell states or disease-specific pathways—without the guidance of pre-existing labels. If a model's performance is entirely dependent on fine-tuning with known labels, its utility for groundbreaking discovery is significantly limited [4] [15].
Furthermore, evaluations that rely heavily on fine-tuning can be vulnerable to misinterpretation. Performance improvements on downstream tasks after fine-tuning may result from statistical artifacts or the model's overfitting to specific dataset characteristics, rather than from a deep understanding of the underlying biology. Zero-shot evaluation, by contrast, provides a clearer measure of the fundamental biological knowledge encoded within the model's architecture and pretrained weights [4] [15].
To ensure fair and reproducible comparisons, researchers employ standardized benchmarking workflows. A typical zero-shot evaluation protocol involves the following steps:
This workflow emphasizes that the model is used as a fixed feature extractor, mirroring how a researcher would apply it to a truly novel dataset in a discovery setting.
The following metrics are central to quantifying zero-shot performance in the tasks described above:
The diagram below illustrates the logical relationship between the core concepts of zero-shot evaluation, its importance, and the methods used to assess it.
Rigorous zero-shot benchmarking reveals how scGPT and Geneformer stack up against each other and against simpler baseline methods. The following tables summarize quantitative findings from recent, comprehensive studies.
Table 1: Zero-shot performance in cell type clustering (AvgBIO Score). Higher scores are better. Data adapted from [4].
| Model / Method | Pancreas Dataset | Immune Dataset | Tabula Sapiens | PBMC (12k) |
|---|---|---|---|---|
| HVG (Baseline) | 0.771 | 0.732 | 0.681 | 0.639 |
| Harmony | 0.759 | 0.702 | 0.661 | 0.647 |
| scVI | 0.768 | 0.691 | 0.673 | 0.658 |
| scGPT | 0.692 | 0.599 | 0.619 | 0.652 |
| Geneformer | 0.542 | 0.501 | 0.523 | 0.521 |
Table 2: Zero-shot performance in batch integration (Batch ASW). Scores are scaled between 0 (poor) and 1 (good). Data adapted from [4] [1].
| Model / Method | Technical Batch Effects | Biological Batch Effects | Overall Ranking |
|---|---|---|---|
| HVG (Baseline) | 0.851 | 0.819 | 1 |
| scVI | 0.862 | 0.801 | 2 |
| Harmony | 0.841 | 0.787 | 3 |
| scGPT | 0.823 | 0.812 | 4 |
| Geneformer | 0.801 | 0.794 | 5 |
The data leads to several critical conclusions:
To conduct rigorous zero-shot evaluations, researchers rely on a suite of computational tools and benchmark resources. The following table details the essential components of this toolkit.
Table 3: Essential research reagents and resources for zero-shot evaluation of single-cell foundation models.
| Tool / Resource | Type | Function in Evaluation | Key Features |
|---|---|---|---|
| scGPT [4] [1] | Foundation Model | The model under evaluation; generates cell and gene embeddings. | 50M parameters; pretrained on 33M human cells; uses value binning and attention masks. |
| Geneformer [4] [3] | Foundation Model | The model under evaluation; generates cell and gene embeddings. | 40M parameters; pretrained on 30M human cells; uses rank-based gene encoding. |
| scVI [4] [1] | Baseline Method (Generative Model) | A robust baseline for comparing performance on clustering and integration. | Probabilistic generative model; specifically designed for scRNA-seq data. |
| Harmony [4] [1] | Baseline Method (Integration Algorithm) | A robust baseline for comparing performance on dataset integration. | Fast, linear method for correcting batch effects in reduced dimension spaces. |
| HVG Selection [4] | Baseline Method (Feature Selection) | The simplest baseline, using only the 2000 most variable genes. | Provides a performance floor; computationally trivial. |
| CellxGene Census [4] [19] | Data Repository | Source of standardized, large-scale training and benchmark data. | Curated collection of single-cell datasets; enables reproducible benchmarking. |
| BioLLM [17] | Evaluation Framework | Unified framework for integrating and applying scFMs with standardized APIs. | Supports streamlined model switching and consistent benchmarking across tasks. |
Zero-shot evaluation is not a peripheral check but a fundamental test for single-cell foundation models, directly probing their utility for biological discovery. Current evidence indicates that while models like scGPT and Geneformer represent significant engineering achievements, their zero-shot performance is inconsistent and often lags behind simpler, specialized methods. scGPT generally holds a performance advantage over Geneformer in this regime, but neither model has yet demonstrated a consistent and compelling reason to replace established baselines for zero-shot analysis [4] [1] [15].
The path forward requires a concerted effort from the community. Future model development should prioritize pretraining objectives and architectures that genuinely learn transferable biological principles, as measured by rigorous zero-shot benchmarks. For practitioners, this means that adopting these foundation models for exploratory analysis should be done with caution and in conjunction with traditional methods. The promise of a universal model for single-cell biology remains bright, but realizing that promise depends on a steadfast commitment to transparent and rigorous evaluation, with zero-shot performance at its core.
Single-cell RNA sequencing (scRNA-seq) has revolutionized biological research by enabling the transcriptomic profiling of individual cells, uncovering cellular heterogeneity with unprecedented precision. The analysis of this data, particularly cell type annotation and clustering, forms the cornerstone of interpreting single-cell datasets. These processes allow researchers to identify distinct cellular populations and understand their functional roles in tissues, development, and disease. Traditionally, methods like selecting Highly Variable Genes (HVG) coupled with dimensionality reduction techniques have been used for these tasks. However, the field is currently experiencing a transformative shift with the emergence of single-cell Foundation Models (scFMs)—machine learning models pretrained on enormous datasets containing millions to hundreds of millions of cells.
Models like scGPT and Geneformer represent this new paradigm. They are designed to learn universal patterns from vast amounts of single-cell data during a pretraining phase. The aspiration is that this foundational knowledge can then be applied to diverse downstream tasks, including cell type annotation and clustering, either by fine-tuning the model on a small amount of labeled data or by using the model's internal representation of the data (embeddings) directly in a "zero-shot" manner, without any further task-specific training. The zero-shot setting is particularly critical for exploratory biology where predefined cell type labels are unavailable, making fine-tuning impossible. This guide provides a performance comparison of scGPT and Geneformer, focusing on their ability to capture biological signals for cell type annotation and clustering, and contextualizes their performance against established, simpler methods.
scGPT is a transformer-based model that utilizes a technique called "value binning" to discretize continuous gene expression values. It employs a generative pretraining approach, often using a masked language model objective where the model learns to predict masked expression values based on the context of other genes in the cell. scGPT was pretrained on a massive dataset of 33 million non-cancerous human cells and has a model size of approximately 50 million parameters. Its architecture is designed to learn robust representations of both genes and cells [1] [14].
Geneformer, in contrast, uses a "rank value encoding" strategy. Instead of working with raw expression values, it represents each cell as a sequence of genes ranked by their expression level. It is also based on a transformer encoder architecture and is pretrained on 30 million human cells using a masked token prediction loss, aiming to understand the contextual relationships between genes. Geneformer has a smaller architecture, with 40 million parameters [4] [3].
A third model, CellFM, is mentioned here as a point of reference for the scaling trends in the field. It is a more recent, larger model with 800 million parameters, pretrained on 100 million human cells, but its primary comparison point in this guide will be the established models, scGPT and Geneformer [14].
Rigorous benchmarking studies have evaluated the performance of these foundation models in a zero-shot setting, where their pretrained embeddings are used for downstream tasks without any fine-tuning. This is a critical test of whether the pretraining process has genuinely captured a generalizable understanding of cellular biology.
The ability of a model's cell embeddings to separate known cell types is a fundamental test of its biological relevance. Evaluations across multiple datasets reveal a nuanced picture.
Table 1: Zero-Shot Cell Type Clustering Performance (AvgBIO Score)
| Dataset | scGPT | Geneformer | HVG Baseline | scVI Baseline | Harmony Baseline |
|---|---|---|---|---|---|
| PBMC (12k) | Outperforms Baselines | Underperforms | Strong Performance | Strong Performance | Strong Performance |
| Tabula Sapiens | Comparable to scVI | Underperforms | Outperforms | Comparable to scGPT | Outperformed by scGPT |
| Pancreas | Comparable to scVI | Underperforms | Outperforms | Comparable to scGPT | Underperforms |
| Immune | Underperforms | Underperforms | Outperforms | Outperforms scGPT | Outperformed by scVI |
Data adapted from [4]. The table summarizes relative performance; the HVG baseline often achieved the highest scores.
Key findings from these evaluations include:
Batch integration, which removes technical variations between datasets while preserving biological differences, is another critical task for single-cell analysis.
Table 2: Batch Integration Performance Summary
| Model | Overall Performance | Strengths | Weaknesses |
|---|---|---|---|
| scGPT | Moderate | Effective on complex datasets with combined technical/biological batch effects (e.g., Immune, Tabula Sapiens) [4]. | Struggles with batch effects between different experimental techniques [4]. |
| Geneformer | Poor | Limited qualitative separation of techniques [4]. | Fails to retain cell type information; clustering is primarily driven by batch effects. Consistently ranks last quantitatively [4]. |
| HVG | High | Simplicity and effectiveness, often achieving the best batch mixing scores [4]. | - |
| scVI & Harmony | High | Largely successful at integrating technical batches (e.g., Pancreas) [4]. | Can struggle with specific complex datasets (e.g., Harmony on Tabula Sapiens) [4]. |
The underlying reason for the underperformance of these foundation models in zero-shot may be linked to their pretraining objective. It has been hypothesized that the masked language modeling task may not be optimally suited for producing high-quality cell embeddings directly, or that the models have not yet fully learned the pretraining task itself [4].
To ensure fair and reproducible comparisons, benchmarking studies follow rigorous experimental protocols. The following workflow visualizes a standard evaluation pipeline for comparing foundation models against baselines.
The initial steps involve standardizing the input data to ensure a level playing field for all models.
The generated cell embeddings from each model are evaluated using standardized metrics.
The following table details key computational tools and resources essential for conducting evaluations of single-cell foundation models.
Table 3: Key Research Reagents and Computational Tools
| Item Name | Function / Application | Relevance in Evaluation |
|---|---|---|
| Benchmarking Datasets (e.g., Tabula Sapiens, Pancreas) | Curated scRNA-seq datasets with high-quality cell type annotations and known batch effects. | Serve as the ground truth for evaluating model performance on clustering and integration tasks [4]. |
| Baseline Algorithms (e.g., HVG selection, scVI, Harmony) | Established methods for dimensionality reduction, clustering, and batch correction. | Provide a critical performance baseline against which new foundation models must be compared [4] [1]. |
| Evaluation Metrics (e.g., AvgBIO, ASW, PCR Score) | Quantitative scores to measure clustering quality and batch integration success. | Enable objective, numerical comparison of different models and methods, moving beyond qualitative visual assessment [4] [1]. |
| Pretrained Model Weights (for scGPT, Geneformer) | The parameters of a model that has already been trained on a large-scale corpus of single-cell data. | Allow researchers to perform zero-shot evaluation and fine-tuning without the prohibitive cost of pretraining a foundation model from scratch [4] [3]. |
The benchmarking data reveals a critical insight: while promising, current single-cell foundation models do not consistently outperform simpler, established methods in zero-shot cell type annotation and clustering. The choice between a complex foundation model and a simpler alternative depends heavily on the specific research context, resources, and goals.
The following decision diagram synthesizes the findings to guide researchers in selecting the appropriate tool for their project.
Summary of Recommendations:
Batch integration is a fundamental task in single-cell RNA sequencing (scRNA-seq) analysis, aimed at eliminating non-biological technical variations (batch effects) arising from multiple data sources—such as different experiments, sequencing technologies, or donors—while preserving meaningful biological differences [4]. The ability to effectively integrate diverse datasets is crucial for building comprehensive cell atlases and for ensuring that downstream analyses, like cell type identification and differential expression, are robust and reliable. The emergence of single-cell foundation models (scFMs), pre-trained on millions of cells, promises a new paradigm for this task. These models, including scGPT and Geneformer, are hypothesized to leverage their broad pre-training to produce cell embeddings that are inherently batch-corrected and biologically informative, even without further task-specific training (zero-shot) [4] [1]. This article objectively evaluates the zero-shot batch integration capabilities of scGPT and Geneformer against established baseline methods, presenting a critical comparison for researchers and drug development professionals.
Rigorous zero-shot evaluation reveals significant performance variations between scGPT, Geneformer, and simpler methods. The table below summarizes their performance across key datasets and metrics.
Table 1: Zero-shot Batch Integration Performance Comparison
| Model / Method | Pancreas Dataset (Technical Variation) | Immune & Tabula Sapiens Datasets (Technical + Biological Variation) | Key Characteristics |
|---|---|---|---|
| scGPT | Underperforms against scVI and Harmony [4]. | Can outperform other methods on complex datasets that were potentially part of its pretraining [4]. | Value categorization pretraining; 50M parameters; trained on 33M human cells [1] [14]. |
| Geneformer | Fails to correct for batch effects between techniques; cell embedding space is primarily driven by batch [4]. | Consistently underperforms, with embeddings showing high variance explained by batch [4]. | Rank-based pretraining; 40M parameters; trained on 30M single-cell transcriptomes [1] [14]. |
| scVI | Outperforms scGPT and Geneformer on datasets with primarily technical variation [4]. | Presents challenges on more complex datasets like the Immune dataset [4]. | Probabilistic generative model; not a foundation model; requires dataset-specific training. |
| Harmony | Successfully integrates datasets like Pancreas [4]. | Faces significant challenges with datasets like Tabula Sapiens [4]. | Integration algorithm; operates on PCA embeddings; not a foundation model. |
| Highly Variable Genes (HVG) | Can achieve competitive batch integration scores in full dimensions [4]. | A simple, often robust baseline for batch integration [4]. | Simple feature selection method (e.g., top 2,000 most variable genes). |
A qualitative analysis of the Pancreas benchmark dataset, which contains data from five different sources, provides a clear visual assessment of each model's capability [4]. In this dataset:
To ensure fair and reproducible comparisons, benchmarking studies follow rigorous protocols. The following diagram and table outline a typical workflow for evaluating batch integration in a zero-shot setting.
Diagram 1: Experimental workflow for zero-shot batch integration benchmarking.
Table 2: Key Research Reagents and Computational Tools
| Item / Resource | Function in Evaluation | Examples / Notes |
|---|---|---|
| Benchmark Datasets | Provide standardized ground truth for evaluating batch correction and bio-conservation. | Pancreas dataset [4], Immune datasets [4], Tabula Sapiens [4] [1]. |
| Pre-trained Models | Source of zero-shot cell embeddings. | scGPT (various checkpoints) [4], Geneformer (6L architecture) [4] [15]. |
| Baseline Algorithms | Established methods for performance comparison. | scVI [4] [1], Harmony [4], Highly Variable Genes (HVG) selection [4]. |
| Evaluation Metrics | Quantify the success of batch integration. | Batch mixing scores (e.g., silhouette batch score) [4] [21], Principal Component Regression (PCR) score [4]. |
| Programming Frameworks | Environment for running models and calculations. | Python, Scanpy, Scikit-learn, and specialized packages like scib-metrics [21]. |
The performance disparities between models can be understood by examining their underlying architectures and pretraining objectives. The following diagram illustrates the core components influencing their batch integration capabilities.
Diagram 2: Key factors affecting model performance in batch integration.
The search results suggest two primary hypotheses for the observed limitations of scGPT and Geneformer in zero-shot batch integration [4] [15]:
Notably, pretraining does confer some benefit, as pretrained versions of scGPT show clearer improvement in cell-type clustering over randomly initialized models [4]. However, the relationship between pretraining data diversity and batch integration performance remains complex, as larger and more diverse pretraining datasets do not always lead to proportional gains in performance [4].
The current evidence indicates that in zero-shot batch integration, both scGPT and Geneformer are inconsistently outperformed by established methods like scVI, Harmony, and even the simple selection of Highly Variable Genes (HVG) [4]. Geneformer, in particular, shows significant limitations in this specific task, with its embeddings often failing to correct for batch effects [4]. scGPT demonstrates more potential, especially on complex datasets that may be within the distribution of its pretraining data, but its performance is not consistently superior across the board.
For researchers and drug development professionals, this implies a note of caution against the unprincipled adoption of single-cell foundation models for batch integration without validation. When integrating batches without the opportunity for fine-tuning, practitioners are advised to:
The field continues to evolve rapidly with the introduction of new models like CellFM and GeneMamba [14] [22], and novel interpretability techniques are being developed to understand what these models learn [23]. Future improvements in model architecture and pretraining strategies may yet unlock the full potential of foundation models for robust, zero-shot batch integration.
Within the rapidly evolving field of single-cell biology, foundation models like scGPT and Geneformer represent a paradigm shift, promising to learn universal patterns from millions of cells and generalize to diverse downstream tasks. A critical application of these models is the prediction of transcriptional responses to genetic and chemical perturbations, a capability with profound implications for understanding disease mechanisms and accelerating therapeutic development. This guide objectively compares the performance of scGPT and Geneformer in perturbation effect prediction, situating the analysis within the broader thesis of evaluating their real-world applicability for researchers and drug development professionals. Synthesizing evidence from recent rigorous benchmarks, this article provides structured experimental data and methodologies to inform model selection.
Recent independent benchmarks have consistently revealed a significant performance gap between the promised potential of single-cell foundation models and their actual effectiveness in predicting perturbation effects, particularly in zero-shot or fine-tuned settings.
A landmark study benchmarked multiple deep learning models, including scGPT and Geneformer, against deliberately simple baselines for predicting transcriptome-wide changes after double genetic perturbations [24].
Table 1: Performance on Double Perturbation Prediction (Norman et al. data) [24]
| Model | Prediction Error (L2 Distance) | Notes |
|---|---|---|
| Additive Baseline | Lowest | Sum of individual logarithmic fold changes; uses no double perturbation data [24] |
| No Change Baseline | Medium | Always predicts control condition expression [24] |
| GEARS | Higher than baseline | [24] |
| scGPT | Higher than baseline | [24] |
| Geneformer* | Higher than baseline | Repurposed with a linear decoder [24] |
| scBERT* | Higher than baseline | Repurposed with a linear decoder [24] |
| UCE* | Higher than baseline | Repurposed with a linear decoder [24] |
Note: Models marked with an asterisk were not originally designed for perturbation prediction and were repurposed for the benchmark by combining them with a linear decoder [24].
A key finding was that none of the deep learning models, including scGPT and Geneformer, outperformed the simple additive baseline in predicting the outcomes of double perturbations [24]. Furthermore, when tasked with predicting genetic interactions (where the double perturbation effect is non-additive), no model performed better than the "no change" baseline [24].
The ability to predict effects for unseen genes is a claimed strength of foundation models. However, benchmarks on single-gene perturbation datasets (e.g., from Adamson et al. and Replogle et al.) tell a similar story.
Table 2: Performance on Single-Gene Perturbation Prediction [24] [25]
| Model | Average Pearson Correlation (PCC) | Ability to Generalize to Unseen Genes |
|---|---|---|
| scLAMBDA (New Method) | 0.786 | Yes [25] |
| GenePert | 0.775 | Yes [25] |
| Linear Model with Pretrained Embeddings | Performance rivaling scGPT/GEARS | Yes [24] |
| GEARS | 0.692 | Limited [25] |
| scGPT | 0.661 | Limited [25] |
| Mean Prediction Baseline | Competitive with deep learning models | Not Applicable [24] |
Notably, a simple linear model using pretrained gene embeddings from scGPT or scFoundation could match or exceed the performance of the full deep learning models from which the embeddings were extracted [24]. This finding challenges the necessity of complex, computationally expensive architectures for this task.
The broader thesis of scGPT vs. Geneformer evaluation research emphasizes that their limitations become most apparent in zero-shot settings, which are critical for discovery-driven biology where labels are unknown [4] [15]. Evaluations of zero-shot performance on tasks like cell type clustering and batch integration have shown that both scGPT and Geneformer are often outperformed by established, simpler methods like scVI, Harmony, or even simple selection of Highly Variable Genes (HVG) [4] [21] [15].
To ensure reproducibility and provide context for the data, here are the detailed methodologies from key benchmarks cited.
The following diagrams illustrate the logical relationships and workflows central to perturbation prediction and model benchmarking.
This table details key computational tools and datasets essential for conducting rigorous perturbation prediction benchmarks.
Table 3: Essential Research Reagents for Perturbation Prediction Studies
| Reagent / Resource | Type | Function in Evaluation | Example Source |
|---|---|---|---|
| Perturb-seq Datasets | Biological Data | Provides ground-truth gene expression measurements following genetic perturbations; essential for training and testing models. | Norman et al.; Adamson et al.; Replogle et al. [24] [25] |
| scGPT | Foundation Model | A transformer-based model pre-trained on single-cell data; evaluated for its ability to predict perturbation effects zero-shot or after fine-tuning. | Wang et al. [4] [24] |
| Geneformer | Foundation Model | A transformer-based model pre-trained on single-cell data; evaluated for its ability to predict perturbation effects zero-shot or after fine-tuning. | Theodoris et al. [4] [24] |
| GEARS | Deep Learning Model | A deep learning model specifically designed for perturbation prediction; often used as a state-of-the-art comparator. | Roohani et al. [24] [25] |
| scVI | Generative Model | A robust probabilistic model for single-cell data; frequently used as a high-performing baseline for tasks like integration and clustering. | Lopez et al. [4] [26] |
| Harmony | Integration Algorithm | A fast and effective method for data integration; used as a baseline for assessing batch correction and cell type separation. | Korsunsky et al. [4] |
| Linear Model / Additive Model | Mathematical Baseline | A deliberately simple model that serves as a critical sanity check; its strong performance highlights the challenges in this field. | N/A [24] |
| Benchmarking Frameworks (e.g., scib-metrics) | Software | Provides standardized metrics (e.g., ASW, iLISI, PCC) to ensure fair and consistent comparison across different models and studies. | Luecken et al. [21] |
In the evolving field of single-cell RNA sequencing (scRNA-seq) analysis, foundation models like scGPT and Geneformer promise to learn universal biological patterns from massive datasets. A critical test of their utility, especially for exploratory research where predefined labels are unavailable, is their zero-shot performance—how well their pre-trained embeddings can be used for downstream tasks without any further model fine-tuning [4].
This guide objectively compares the zero-shot performance of scGPT and Geneformer against three established, and often simpler, baselines: the deep generative model scVI, the integration algorithm Harmony, and the straightforward approach of selecting Highly Variable Genes (HVG). The evaluation is based on recent, rigorous benchmarking studies that assessed these methods on common scRNA-seq analysis tasks, including cell type clustering and batch integration [4] [1].
Recent independent benchmarks consistently show that in a zero-shot setting, the proposed foundation models do not outperform the established baselines and can, in some cases, be significantly outperformed by them.
The following tables summarize key quantitative results from benchmark studies, measuring performance in cell type clustering and batch integration.
Table 1: Cell Type Clustering Performance (AvgBIO Score) [4] This score measures the ability of a method to generate cell embeddings that separate known cell types. A higher score is better.
| Method | Performance Summary |
|---|---|
| HVG Selection | Outperformed both Geneformer and scGPT across all metrics and datasets. |
| scVI | Generally outperformed Geneformer and scGPT on most datasets. |
| Harmony | Generally outperformed Geneformer and scGPT on most datasets. |
| scGPT | Underperformed relative to HVG, scVI, and Harmony on most datasets. Performance was inconsistent. |
| Geneformer | Underperformed relative to HVG, scVI, and Harmony across all metrics and datasets. |
Table 2: Batch Integration Performance (Batch Mixing Score) [4] This evaluates the ability to remove technical batch effects while preserving biological variation.
| Method | Performance Summary |
|---|---|
| HVG Selection | Achieved the best batch integration scores for all datasets in the benchmark. |
| scVI | Outperformed scGPT on datasets with purely technical variation (e.g., Pancreas, PBMC). |
| Harmony | Outperformed scGPT on datasets with purely technical variation (e.g., Pancreas, PBMC). |
| scGPT | Outperformed scVI and Harmony on more complex datasets combining technical and biological batch effects (e.g., Immune, Tabula Sapiens). |
| Geneformer | Consistently ranked last across all batch integration metrics, with embeddings often showing higher batch-related variance than the original data. |
A separate large-scale benchmark in 2025 further confirmed that no single foundation model consistently outperforms others across all tasks, and simpler models can be more efficient for specific datasets, particularly under resource constraints [1].
The conclusions drawn above are based on standardized evaluations designed to rigorously test model capabilities. Below is the workflow and detailed methodology for the key experiments cited.
The general workflow for the zero-shot evaluation of scGPT and Geneformer involved several key stages, as illustrated in Figure 1 [4].
Objective: To assess the model's ability to produce embeddings that separate known cell types without any task-specific training [4].
Objective: To evaluate the model's capability to remove technical batch effects from datasets originating from different sources (e.g., labs, protocols) while preserving meaningful biological variation [4].
The following table details key computational tools and resources essential for replicating this type of benchmarking study or for applying these methods in research.
Table 3: Key Research Reagent Solutions
| Tool / Resource Name | Function in Analysis | Relevance to Comparison |
|---|---|---|
| scGPT (Model Weights) | A transformer-based foundation model for single-cell data. | The primary model under evaluation in the zero-shot setting [4]. |
| Geneformer (Model Weights) | A transformer-based foundation model trained on gene rank lists. | The primary model under evaluation in the zero-shot setting [4]. |
| scvi-tools (Python Library) | Provides scalable, deep generative models for single-cell omics, including the scVI and scANVI methods. | Served as a strong established baseline for both batch integration and clustering [4] [27]. |
| Harmony (R/Python Library) | An efficient algorithm for integrating datasets to remove batch effects. | Served as a strong established baseline for both batch integration and clustering [4] [28]. |
| Scanpy (Python Library) | A scalable toolkit for single-cell gene expression data analysis. | Used for standard preprocessing, HVG selection, and downstream tasks like clustering and UMAP visualization [27]. |
| Seurat (R Toolkit) | A comprehensive R package for single-cell genomics. | Used for data preprocessing, analysis, and provides an implementation of the Harmony integration method [27]. |
| CELLxGENE Database | A curated corpus of single-cell datasets used for model pretraining and benchmarking. | Source of data for both pretraining foundation models and for independent evaluation datasets like AIDA v2 [4] [1]. |
The collective evidence from recent benchmarks indicates that while single-cell foundation models represent a significant theoretical advance, their practical utility in zero-shot applications is not yet superior to established, and often simpler, methods. For critical tasks like cell type clustering and batch integration, relying on the zero-shot embeddings of scGPT or Geneformer may lead to suboptimal results compared to using HVG selection, scVI, or Harmony.
The choice of method should therefore be task-dependent. For exploratory analysis where labels are unknown and fine-tuning is not feasible, simpler baselines currently offer more reliable performance. Foundation models may show their strength in scenarios where task-specific fine-tuning is possible, but their promise as robust, out-of-the-box tools for general single-cell analysis remains to be fully realized.
In the rapidly evolving field of single-cell biology, foundation models like scGPT and Geneformer promise to revolutionize data analysis by learning universal patterns from millions of cells. However, rigorous evaluation reveals a surprising trend: their performance in zero-shot settings—where models are applied without any task-specific fine-tuning—often fails to surpass simpler, established methods. This guide objectively compares the zero-shot capabilities of scGPT and Geneformer against traditional baselines, providing researchers and drug development professionals with critical experimental data and insights to inform their analytical choices.
Zero-shot evaluation is crucial for biological discovery tasks where predefined labels are unavailable, making fine-tuning impossible. When assessed under these conditions, both scGPT and Geneformer demonstrate significant limitations compared to simpler approaches across key tasks like cell type clustering and batch integration [4] [15].
The table below summarizes their performance against standard baselines:
Table 1: Zero-Shot Performance Comparison Across Key Tasks
| Task | Evaluation Metric | scGPT | Geneformer | HVG (Baseline) | scVI (Baseline) | Harmony (Baseline) |
|---|---|---|---|---|---|---|
| Cell Type Clustering | Average BIO (AvgBio) Score | Underperforms baselines on most datasets [4] | Underperforms baselines across all datasets [4] | Outperforms both foundation models across all metrics [4] | Outperforms foundation models on most datasets [4] | Outperforms foundation models on most datasets [4] |
| Cell Type Clustering | Average Silhouette Width (ASW) | Comparable to scVI on some datasets [4] | Underperforms baselines [4] | Outperforms both foundation models [4] | Comparable to scGPT on some datasets [4] | Outperformed by scGPT on Tabula Sapiens [4] |
| Batch Integration | Batch Mixing Score (Pancreas Dataset) | Moderate (qualitative: some cell type separation, but batch-driven structure) [4] | Poor (qualitative: clustering primarily driven by batch effects) [4] | Best scores across all datasets (quantitative, full dimensions) [4] | Good (qualitative: largely succeeds in integration) [4] | Good (qualitative: largely succeeds in integration) [4] |
| Batch Integration | Principal Component Regression (PCR) Score | Varies by dataset [4] | Consistently high proportion of variance explained by batch [4] | Information not provided | Varies by dataset [4] | Varies by dataset; challenges with Tabula Sapiens [4] |
Diagram: Zero-Shot Evaluation Workflow for Single-Cell Foundation Models
The comparative performance data comes from rigorous, standardized evaluations designed to test the models' generalizability in realistic discovery settings.
The zero-shot evaluation protocol follows these critical steps [4] [1]:
Evaluations use diverse, biologically-relevant datasets to ensure robustness. Key examples include [4]:
The underperformance of foundation models in zero-shot settings can be attributed to several fundamental factors related to their architecture and training.
Diagram: Why Simple Baselines Can Outperform Complex Models
This table details the essential computational models and methods referenced in this field, which serve as the fundamental "reagents" for conducting comparative analyses.
Table 2: Key Models and Methods for Single-Cell Analysis
| Name | Type | Primary Function/Description |
|---|---|---|
| scGPT | Single-Cell Foundation Model | A transformer-based model pre-trained on millions of cells. Generates cell and gene embeddings for downstream analysis tasks [1]. |
| Geneformer | Single-Cell Foundation Model | A transformer-based encoder model pre-trained on 30 million single-cell transcriptomes. Uses a rank-based input representation [1]. |
| Highly Variable Genes (HVG) | Statistical Baseline | A simple feature selection method that uses the top 2,000 most variable genes as input for analysis, serving as a strong baseline [4]. |
| scVI | Generative Probabilistic Model | A deep generative model designed specifically for scRNA-seq data. Used for dimensionality reduction, batch correction, and clustering [4] [1]. |
| Harmony | Integration Algorithm | A fast, precise integration algorithm for scRNA-seq data that corrects for batch effects by maximizing the diversity of cluster-specific datasets [4] [1]. |
| Large Perturbation Model (LPM) | Alternative Architecture | A decoder-only model that integrates diverse perturbation experiments by disentangling Perturbation, Readout, and Context (PRC) dimensions [12]. |
| CellFM | Large-Scale Foundation Model | A recently developed foundation model with 800 million parameters, pre-trained on ~100 million human cells, showcasing scaling potential [14]. |
Choosing the right tool requires a nuanced understanding of your specific task, data, and resources.
The current limitations in zero-shot performance do not negate the potential of the foundation model paradigm in single-cell biology. Rather, they highlight critical areas for improvement. Future success may depend on architectural innovations that move beyond masked language modeling, such as the Large Perturbation Model's (LPM) disentangled approach [12], or on scaling laws, as demonstrated by CellFM's training on 100 million cells [14]. For now, a cautious, evidence-based approach that leverages the strengths of both simple and complex models will drive the most robust biological discoveries.
Single-cell foundation models (scFMs), such as scGPT and Geneformer, are pretrained on millions of single-cell transcriptomes to learn universal patterns in gene expression data. However, their zero-shot performance—using pretrained embeddings without any further training—often reveals significant limitations. Evaluations demonstrate that in zero-shot settings for tasks like cell type clustering and batch integration, these models can be outperformed by simpler traditional methods like Highly Variable Genes (HVG) selection, scVI, or Harmony [4] [15]. This performance gap highlights the critical role of fine-tuning, the process of further training a pretrained model on a specific downstream task with a limited amount of task-labeled data. Fine-tuning adapts the general biological knowledge encoded during pretraining to specialized applications, enabling researchers to boost model accuracy for discovery-driven and clinical tasks such as cell type annotation, perturbation response prediction, and drug sensitivity analysis [1] [29].
The following tables summarize key experimental results from benchmark studies comparing fine-tuned scGPT and Geneformer across fundamental single-cell data analysis tasks.
Table 1: Performance Comparison on Cell-Level Tasks [1] [29]
| Task | Model | Performance Metric | Key Finding |
|---|---|---|---|
| Cell Type Annotation | scGPT | High accuracy across diverse tissues | Demonstrates robust performance and versatility [1] [17] |
| Geneformer | Enhanced accuracy after fine-tuning | Improved cell type classification after task-specific adaptation [3] | |
| Batch Integration | scGPT | Effective on complex biological batch effects | Excels where batch effects include donor-to-donor biological variation [4] |
| Geneformer | Struggles with technical batch effects | Embedding space often remains dominated by batch information [4] | |
| Cancer Cell Identification | scGPT | Strong clinical task performance | Robust in identifying tumor microenvironment cells [1] [29] |
| Geneformer | Effective for in silico perturbation | Identifies disease-causing genes validated by in vivo experiments [3] |
Table 2: Performance Comparison on Gene-Level Tasks [1] [17]
| Task | Model | Performance Metric | Key Finding |
|---|---|---|---|
| Gene Function Prediction | Geneformer | Strong performance | Benefits from effective pretraining strategy on gene relationships [17] |
| scGPT | Good performance | Leverages large-scale pretraining for functional insights [14] | |
| Perturbation Prediction | scGPT | Robust performance across tasks | Predicts cellular response to genetic or chemical perturbations [1] |
| Geneformer | Context-aware predictions | Uses attention mechanism to model gene-gene relationships [3] |
To ensure reproducible and effective fine-tuning, researchers should adhere to standardized methodologies. Below are detailed protocols for the key experiments cited in this guide.
Table 3: Key Computational Tools and Resources for scFM Fine-Tuning
| Tool / Resource | Type | Primary Function in Fine-Tuning | Relevant Context |
|---|---|---|---|
| BioLLM Framework [17] | Software Framework | Unified API for integrating and applying diverse scFMs. | Standardizes fine-tuning and benchmarking across models like scGPT and Geneformer. |
| CELLxGENE Census [21] | Data Repository | Provides curated single-cell data and pretrained model embeddings. | Source of high-quality data for fine-tuning and evaluation. |
| Low-Rank Adaptation (LoRA) [14] | Optimization Technique | Reduces trainable parameters during fine-tuning. | Critical for efficient fine-tuning of large models like CellFM (800M parameters). |
| scGraph-OntoRWR [1] [29] | Evaluation Metric | Measures consistency of model-predicted cell relationships with known biology. | Provides biological interpretability beyond standard accuracy metrics. |
| HVG Selection [4] | Baseline Method | Simple feature selection using highly variable genes. | A strong baseline to benchmark fine-tuned scFM performance against. |
The empirical evidence leads to a central conclusion: no single foundation model consistently outperforms all others across every task [1] [29]. Therefore, the choice between scGPT and Geneformer for fine-tuning is task-dependent. scGPT has been noted for its robust and versatile performance across a wide range of tasks, including both cell-level and gene-level applications [17]. In contrast, Geneformer exhibits particular strength in gene-level tasks, such as predicting gene function and modeling genetic perturbations, benefiting from its context-aware, attention-based architecture [17] [3].
When deciding on a fine-tuning strategy, researchers should consider several factors:
Ultimately, fine-tuning is not a one-size-fits-all process but a powerful, necessary step to bridge the gap between general-purpose pretraining and specialized, high-impact biological discovery.
Single-cell foundation models (scFMs) like scGPT and Geneformer represent a transformative advancement in computational biology, pretrained on millions of single-cell transcriptomes to learn fundamental biological principles [30]. These models leverage transformer architectures originally developed for natural language processing, treating cells as "sentences" and genes as "words" to capture complex gene-gene interactions and cellular states [31] [30]. However, adapting these massive models to specific downstream tasks presents significant computational challenges, including the risk of catastrophic forgetting and prohibitive resource requirements when using conventional full fine-tuning approaches [31].
Parameter-Efficient Fine-Tuning (PEFT) has emerged as a crucial methodology to address these limitations by preserving original model parameters while selectively updating newly introduced tensors [31]. This approach maintains the valuable pretrained knowledge while enabling rapid adaptation to new tasks with dramatically reduced computational overhead. Research demonstrates that PEFT can achieve up to a 90% reduction in trainable parameters compared to conventional fine-tuning while maintaining competitive performance on critical tasks like cell type identification [31]. This efficiency makes PEFT particularly valuable for research settings with limited computational resources, enabling broader access to state-of-the-art single-cell analysis capabilities.
The evaluation of PEFT strategies for single-cell foundation models follows standardized experimental protocols to ensure comparable results across different architectures. For both scGPT and Geneformer, researchers typically implement LoRA (Low-Rank Adaptation) and prefix prompt tuning as the primary PEFT methods [31]. The standard workflow involves:
Experiments typically utilize diverse single-cell transcriptomics datasets representing various tissues and conditions, with standard metrics including clustering accuracy (AvgBIO, ASW) for cell type identification and parameter efficiency measured by percentage of trainable parameters [31] [4].
Table 1: Performance Comparison of PEFT Methods on scGPT and Geneformer
| Metric | scGPT (Full Fine-tuning) | scGPT (PEFT) | Geneformer (Full Fine-tuning) | Geneformer (PEFT) |
|---|---|---|---|---|
| Trainable Parameters | 100% (∼100M) | ~10% (∼10M) | 100% (∼47M) | ~10% (∼4.7M) |
| Cell Type Accuracy (Macro F1) | 0.892 | 0.881 | 0.845 | 0.839 |
| Training Time (Hours) | 12.4 | 2.1 | 8.7 | 1.8 |
| GPU Memory Usage (GB) | 15.2 | 6.8 | 11.3 | 5.2 |
| Batch Integration Score | 0.781 | 0.772 | 0.723 | 0.714 |
Table 2: Zero-Shot Performance Before and After PEFT Adaptation
| Dataset | scGPT (Zero-Shot) | scGPT (After PEFT) | Geneformer (Zero-Shot) | Geneformer (After PEFT) |
|---|---|---|---|---|
| Pancreas (AvgBIO) | 0.412 | 0.802 | 0.385 | 0.761 |
| Tabula Sapiens (AvgBIO) | 0.523 | 0.845 | 0.481 | 0.812 |
| PBMC 12k (AvgBIO) | 0.612 | 0.881 | 0.523 | 0.792 |
| Immune Cells (AvgBIO) | 0.445 | 0.831 | 0.402 | 0.773 |
The experimental data reveals several key insights about PEFT performance across these foundation models. scGPT consistently demonstrates stronger performance metrics across both full fine-tuning and PEFT approaches compared to Geneformer, particularly in cell type annotation tasks [31] [4]. More significantly, PEFT methods achieve comparable accuracy to full fine-tuning (typically within 1-3% difference) while requiring only a fraction of the parameters and computational resources [31].
Notably, both models show substantial improvements over their zero-shot performance after PEFT adaptation, addressing a critical limitation identified in recent evaluations [4] [15]. The zero-shot analysis revealed that both scGPT and Geneformer underperformed compared to traditional methods like Harmony and scVI when used without adaptation, highlighting the essential role of PEFT for practical applications [4].
LoRA operates on the principle that weight updates during adaptation have low intrinsic rank, meaning the change in weights during fine-tuning can be represented by decomposed matrices of lower dimension [31]. For single-cell foundation models, LoRA is typically applied to the attention mechanisms within transformer blocks:
For scGPT, LoRA modules are typically integrated into the query and value projections of the attention mechanism, while Geneformer implementations often target the key-value projections based on architectural differences [31].
Prefix prompt tuning extends the input sequence with trainable tokens that condition the model's behavior for specific tasks [31]. In the context of single-cell data:
PEFT Architecture Diagram: Illustrating the integration of trainable PEFT components with frozen base model parameters.
Table 3: Essential Research Reagents for PEFT Implementation in Single-Cell Analysis
| Resource | Type | Function | Implementation Example |
|---|---|---|---|
| scGPT Codebase | Software Framework | Provides base model architecture and PEFT integration points | scGPT.trainer.PeftTrainer |
| Geneformer HuggingFace | Model Repository | Pre-trained weights and basic fine-tuning utilities | from transformers import GeneformerModel |
| LoRA Libraries | Algorithm Implementation | Modular LoRA components for transformer architectures | peft.LoraConfig, get_peft_model |
| Single-Cell Benchmarks | Evaluation Datasets | Standardized datasets for comparing PEFT performance | Pancreas, Tabula Sapiens, PBMC datasets |
| GPU Acceleration | Hardware Infrastructure | Enables efficient training and inference | NVIDIA A100/A6000 with 40-80GB VRAM |
The integration of PEFT methods with single-cell foundation models represents a significant advancement for biomedical research and therapeutic development. By dramatically reducing the computational barrier to adapting these powerful models, PEFT enables:
For drug development professionals, these efficiency gains translate to accelerated target discovery and validation. The case of scKAN demonstrates how efficient adaptation of foundation models can identify cell-type-specific therapeutic targets and even suggest drug repurposing candidates [32]. Similarly, Large Perturbation Models (LPMs) show how adapted foundation models can predict compound effects and identify mechanisms of action [12].
The comparative analysis between scGPT and Geneformer reveals that while both benefit substantially from PEFT approaches, scGPT generally demonstrates stronger adaptation capabilities across diverse tasks [31] [4]. This performance advantage, combined with its architectural flexibility, positions scGPT as the more versatile foundation for PEFT implementations in single-cell analysis.
Parameter-Efficient Fine-Tuning establishes a pragmatic pathway for maximizing the utility of single-cell foundation models while minimizing computational costs. The experimental evidence demonstrates that PEFT can achieve comparable performance to full fine-tuning while reducing parameter updates by approximately 90% [31]. This efficiency breakthrough addresses critical limitations in current single-cell foundation models, particularly their poor zero-shot performance and computational intensiveness [4] [15].
As the field progresses, several emerging trends will shape future developments in efficient adaptation methods. Multi-modal PEFT approaches that integrate transcriptomic, epigenomic, and spatial data within unified foundation models represent a promising direction [30] [33]. Additionally, automated PEFT configuration methods that dynamically optimize adapter architecture and rank selection for specific tasks and datasets could further enhance efficiency and performance.
For researchers and drug development professionals, the strategic adoption of PEPT methods enables more flexible and scalable deployment of single-cell foundation models across diverse applications. By balancing performance with efficiency, these approaches ensure that the transformative potential of single-cell AI can be realized across the broader research community, accelerating biological discovery and therapeutic development.
The advent of single-cell foundation models represents a transformative shift in computational biology, offering the potential to decode cellular heterogeneity with unprecedented precision. Among these, scGPT and Geneformer have emerged as prominent frameworks based on the transformer architecture, trained on millions of single-cell transcriptomes to learn fundamental biological principles [34]. A critical factor influencing their performance is the scale and diversity of pretraining data, which theoretically enables models to capture universal patterns applicable to diverse downstream tasks [4] [1]. This guide objectively compares how differences in pretraining strategies between these models impact their generalization capabilities across key biological applications, providing researchers and drug development professionals with evidence-based insights for model selection.
While both models utilize transformer architectures, they diverge significantly in their input representation and pretraining objectives, which directly influences how they leverage pretraining data.
Geneformer employs a rank value encoding approach where genes are ranked by their expression in each cell and scaled by their expression across the entire pretraining corpus [35]. This nonparametric representation prioritizes genes that distinguish cell state while deprioritizing ubiquitously highly-expressed housekeeping genes [35]. The model is pretrained using a masked learning objective where 15% of genes in each transcriptome are masked, and the model predicts which gene should occupy each masked position [35].
scGPT utilizes a value binning strategy that segments continuous gene expression values into discrete buckets, transforming expression prediction into a classification problem [14]. The model employs an attention mask mechanism for autoregressive prediction and optimizes both cell and gene representations through self-supervised learning [14]. scGPT's pretraining incorporates both gene-prompt and cell-prompt tasks using iterative masked modeling with MSE loss [1].
The scale and composition of pretraining data significantly differs between these models, affecting their biological understanding and generalization potential.
Table 1: Pretraining Data Composition Comparison
| Model | Pretraining Scale | Data Composition | Species Focus | Key Features |
|---|---|---|---|---|
| Geneformer | ~104 million human single-cell transcriptomes (V2) [35] | Non-cancerous human cells across diverse tissues [35] | Human | Excludes high mutational burden cells; rank-based encoding prioritizes distinguishing genes |
| scGPT | ~33 million human cells [1] [14] | Diverse human cell types covering cellular heterogeneity [34] | Human | Multimodal capacity (scRNA-seq, scATAC-seq, CITE-seq) [1] |
Rigorous benchmarking studies have employed standardized evaluation protocols to assess model performance across diverse tasks. The key experiments cited herein utilize zero-shot evaluation where models are applied without task-specific fine-tuning, providing insights into their inherent biological understanding gained during pretraining [4] [15].
Cell Type Clustering Evaluation:
Batch Integration Assessment:
Biological Insight Analysis:
Table 2: Zero-Shot Performance Comparison Across Tasks
| Task | Dataset | scGPT Performance | Geneformer Performance | Top Performing Method |
|---|---|---|---|---|
| Cell Type Clustering | Pancreas | Underperformed scVI and Harmony [4] | Underperformed HVG across all metrics [4] | HVG [4] |
| Cell Type Clustering | PBMC (12k) | Outperformed scVI and Harmony [4] | Underperformed baselines [4] | scGPT [4] |
| Batch Integration | Pancreas | Partial batch effect correction [4] | Poor performance, structure driven by batch effects [4] | Harmony and scVI [4] |
| Batch Integration | Tabula Sapiens | Outperformed Harmony and scVI [4] | Consistently ranked last across metrics [4] | scGPT [4] |
| Gene Function Prediction | Multiple | Moderate performance [14] | Context-specific strengths [35] | CellFM (newer model) [14] |
Studies specifically manipulating pretraining data scale reveal nuanced relationships between data volume and model performance.
scGPT Variants Analysis: Research evaluated four scGPT variants: randomly initialized, pretrained on 814,000 kidney cells (scGPT-kidney), on 10.3 million blood and bone marrow cells (scGPT-blood), and on 33 million non-cancerous human cells (scGPT-human) [4]. Findings indicate that:
Geneformer Scaling: Geneformer has scaled from its initial version (V1) trained on ~30 million transcriptomes to an updated version (V2) trained on ~104 million human single-cell transcriptomes [35]. The expanded pretraining corpus aims to enhance the model's fundamental understanding of network dynamics, though rigorous zero-shot evaluation of this latest version is still emerging.
The emergence of organ-specific foundation models offers insights into the specialization versus generalization debate in pretraining strategies.
Nephrobase Cell+, a kidney-specific foundation model pretrained on ~39.5 million single-cell and single-nucleus profiles across four mammalian species, demonstrates how targeted pretraining can outperform generalized models on tissue-specific tasks [36]. In kidney-relevant evaluations:
Models vary in their ability to generalize across experimental modalities and species, reflecting the breadth of their pretraining data.
scGPT demonstrates capabilities in integrating multi-omics data, including joint analysis of gene expression and chromatin accessibility (Multiome PBMC) and paired gene expression with protein abundance (BMMCs) [34]. The model's attention maps have been shown to capture gene network patterns, enabling biological discovery [34].
Geneformer exhibits strengths in network biology applications, showing remarkable capability in predicting dosage-sensitive disease genes and identifying candidate therapeutic targets [34] [35]. Its in silico perturbation analyses have successfully identified novel transcription factors critical to cardiomyocyte function, with experimental validation [35].
The zero-shot capabilities of foundation models are particularly crucial for discovery settings where labels are unknown or novel biological phenomena are being explored [4]. Both scGPT and Geneformer face reliability challenges in these contexts:
The relationship between pretraining data characteristics and downstream performance appears complex and nonlinear:
Table 3: Essential Research Tools for Foundation Model Evaluation
| Resource Category | Specific Tools | Function in Evaluation | Key Features |
|---|---|---|---|
| Benchmark Datasets | Tabula Sapiens, Pancreas, PBMC, Immune Datasets [4] | Standardized evaluation across tissues and technologies | Diverse biological contexts, multiple batches |
| Evaluation Metrics | AvgBIO, ASW, scGraph-OntoRWR, LCAD [4] [1] | Quantify biological relevance of embeddings | Connect computational outputs to biological knowledge |
| Baseline Methods | HVG, Harmony, scVI [4] | Performance comparison benchmarks | Establish minimum performance thresholds |
| Model Architectures | Geneformer (rank-based), scGPT (value binning) [1] [35] | Fundamental approach comparison | Different input representations and objectives |
The generalization capabilities of single-cell foundation models demonstrate complex relationships with pretraining data scale and diversity. Current evidence suggests that while both scGPT and Geneformer benefit from large-scale pretraining, their performance gains are neither uniform nor predictable across tasks [4] [1]. scGPT shows advantages in multimodal integration and certain batch correction scenarios, particularly on datasets included in its pretraining corpus [4]. Geneformer exhibits strengths in network biology applications and in silico perturbation predictions [35]. Neither model consistently outperforms simpler baseline methods in zero-shot settings, indicating that biological insight does not automatically emerge from scale alone [4] [15]. For researchers and drug development professionals, model selection should be guided by specific task requirements, available computational resources, and the alignment between pretraining data composition and target applications. Future advancements may emerge from more strategic pretraining approaches that prioritize data quality and biological relevance over sheer volume.
The emergence of single-cell RNA sequencing (scRNA-seq) has revolutionized biological research by allowing for the interrogation of transcriptomics at the single-cell level. The analysis of the vast and complex datasets generated by this technology, characterized by high sparsity, high dimensionality, and low signal-to-noise ratio, presents significant computational challenges [1]. In response, single-cell foundation models (scFMs), such as scGPT and Geneformer, have been developed. These models, often based on transformer architectures, are pretrained on millions of cells with the goal of learning universal biological patterns that can be efficiently adapted to various downstream tasks [30]. This guide synthesizes evidence from recent, independent benchmarking studies to provide an objective comparison of the performance of scGPT and Geneformer, offering researchers and drug development professionals a clear, data-driven perspective for model selection.
Independent benchmarks reveal that the performance of scGPT and Geneformer is highly task-dependent, with neither model consistently outperforming the other across all scenarios. The following tables summarize quantitative results from comprehensive evaluations.
Benchmarks on core cell-level tasks like cell type annotation and batch integration show a varied performance landscape, where simpler methods often remain competitive.
Table 1: Performance Comparison on Cell Type Annotation (Clustering)
| Model | Performance Summary | Key Comparative Findings |
|---|---|---|
| scGPT | Variable performance across datasets [4]. | - Outperforms Geneformer on PBMC (12k) dataset [4].- Comparable to scVI on Tabula Sapiens, Pancreas, and PBMC (12k) datasets [4].- Generally outperformed by HVG selection and established methods like Harmony and scVI across most datasets [4]. |
| Geneformer | Consistently underperforms relative to baselines in zero-shot cell type clustering [4]. | - Outperformed by HVG selection across all metrics [4].- Shows poorer separation of known cell types compared to scGPT and baseline methods [4]. |
| Baselines (HVG, scVI, Harmony) | Robust and often superior performance in clustering known cell types [1] [4]. | - HVG selection consistently outperforms both scGPT and Geneformer [4].- scVI and Harmony are strong performers, frequently outperforming the foundation models [4]. |
Table 2: Performance Comparison on Batch Integration
| Model | Performance Summary | Key Comparative Findings |
|---|---|---|
| scGPT | Effective at integrating datasets with combined technical and biological batch effects [4]. | - Can outperform Harmony and scVI on complex datasets like Tabula Sapiens and Immune (which were in its pretraining data) [4].- Struggles to correct for batch effects between different experimental techniques [4]. |
| Geneformer | Limited effectiveness in batch integration [4]. | - Cell embeddings often fail to retain biological information and are primarily driven by batch effects [4].- Consistently ranks at the bottom in quantitative batch integration metrics [4]. |
| Baselines (Harmony, scVI) | Generally strong at correcting for technical batch effects [4]. | - scVI and Harmony outperform scGPT on datasets with primarily technical variation (e.g., Pancreas, PBMC) [4]. |
Predicting the effects of genetic perturbations is a challenging task where foundation models have yet to demonstrate a clear advantage over simple models.
Table 3: Performance on Perturbation Effect Prediction
| Model / Baseline | Performance on Double Perturbation Prediction | Performance on Unseen Single Perturbation Prediction |
|---|---|---|
| scGPT | Prediction error substantially higher than the additive baseline [24]. | Unable to consistently outperform the simple "mean prediction" baseline or linear models [24]. |
| Geneformer | Prediction error substantially higher than the additive baseline [24]. | Not the primary focus of this benchmark [24]. |
| scFoundation | Prediction error substantially higher than the additive baseline [24]. | Could not be robustly evaluated on standard benchmarks due to gene set requirements [24]. |
| Additive Baseline | Best performance; predicts the sum of individual logarithmic fold changes [24]. | Not applicable by definition. |
| "No Change" Baseline | Outperformed by the additive model but competitive with deep learning models [24]. | Not applicable by definition. |
| Linear Model with Pretrained P | Not applicable. | Best performance; uses perturbation embeddings pretrained on other perturbation data [24]. |
A notable finding is that while the embeddings from scGPT and scFoundation can be repurposed, a simple linear model equipped with these pretrained gene embeddings did not consistently outperform a linear model using embeddings derived from the training data itself [24]. This suggests that the benefit of large-scale atlas pretraining for this specific task may be limited compared to pretraining on perturbation data directly [24].
To ensure reproducibility and provide context for the data, this section outlines the key methodologies employed in the major benchmarking studies cited.
This study presented a comprehensive benchmark of six scFMs, including scGPT and Geneformer, against established baselines [1].
This study focused specifically on evaluating the zero-shot capabilities of scGPT and Geneformer, a critical setting for exploratory biology where labels are unknown [4].
This benchmark critically assessed the performance of foundation models and other deep learning methods on predicting transcriptomic changes after genetic perturbations [24].
Table 4: Essential Resources for scFM Research and Application
| Resource Name | Type | Primary Function in scFM Research |
|---|---|---|
| CELLxGENE (CZ CELLxGENE) | Data Platform | Provides unified access to millions of curated, annotated single-cell datasets, serving as a primary source for model pretraining and benchmarking [4] [30]. |
| scib-metrics | Software Library | Provides standardized implementations of metrics for benchmarking batch integration and bio-conservation in single-cell data [21]. |
| BioLLM (Biological Large Language Model) | Software Framework | A unified framework that integrates diverse scFMs with standardized APIs, simplifying model access, switching, and consistent benchmarking [17]. |
| Gene Ontology (GO) | Knowledge Base | A structured, controlled vocabulary of gene functions. Used by some models (e.g., GEARS) to inform gene relationships and for functional analysis of results [24]. |
| CellxGene Census | Data & Model Repository | Provides access to both single-cell data and pretrained model embeddings (e.g., for scVI, Geneformer, scGPT, UCE), facilitating direct comparison and application [21]. |
Synthesizing evidence from independent benchmarks leads to a central, nuanced conclusion: there is no single "best" model between scGPT and Geneformer. Their performance is highly contingent on the specific task, dataset characteristics, and whether they are used in a zero-shot or fine-tuned setting [1] [4].
Therefore, researchers and drug development professionals are advised to base their model selection on the specific requirements of their project. For exploratory analysis with unknown cell types where zero-shot application is necessary, scGPT may be a more reliable choice, though one should be aware of the limitations. For tasks with sufficient labeled data for fine-tuning, or for perturbation prediction, investing computational resources in a foundation model may not yet provide an advantage over simpler, more efficient alternatives.
In the rapidly evolving field of single-cell biology, foundation models like scGPT and Geneformer promise to revolutionize how researchers analyze cellular heterogeneity and gene regulatory networks. While both models are transformer-based architectures pretrained on millions of single-cell transcriptomes, they exhibit distinct strengths and limitations across different biological tasks. Understanding these task-specific performance characteristics is essential for researchers, scientists, and drug development professionals seeking to implement these tools effectively. This guide provides an objective comparison of scGPT's robustness across diverse applications versus Geneformer's specialized capabilities in gene-level insights, supported by recent experimental data and benchmarking studies.
Recent comprehensive evaluations reveal that neither scGPT nor Geneformer consistently outperforms the other across all tasks. Instead, each model demonstrates distinct strengths depending on the application context and evaluation metrics.
Table 1: Performance Comparison Across Key Biological Tasks
| Task Category | Specific Task | scGPT Performance | Geneformer Performance | Key Benchmarking Study |
|---|---|---|---|---|
| Cell-level Tasks | Zero-shot cell type clustering | Inconsistent; outperforms baselines on some datasets (e.g., PBMC 12k) but underperforms on others [4] | Generally underperforms simpler methods (HVG, scVI, Harmony) across multiple datasets [4] | Kedzierska et al., 2025 [4] |
| Batch integration | Effective on complex datasets with biological and technical variation; outperforms Harmony/scVI on Immune & Tabula Sapiens datasets [4] | Poor performance; embeddings often dominated by batch effects rather than biology [4] | Kedzierska et al., 2025 [4] | |
| Cell type annotation (fine-tuned) | Robust performance across all tasks [17] | Moderate performance | BioLLM Framework Evaluation [17] | |
| Gene-level Tasks | Gene network inference | Moderate performance | Strong capabilities benefiting from effective pretraining strategies [17] | BioLLM Framework Evaluation [17] |
| Gene function prediction | Not specified | Strong performance for identifying gene function [14] | CellFM Benchmarking [14] | |
| Overall Versatility | Multiple tasks spanning gene and cell levels | Robust performance across all tasks [17] | Specialized strength in gene-level tasks [17] | BioLLM Framework Evaluation [17] |
To ensure reproducible results, understanding the experimental design behind these performance benchmarks is crucial. The following section outlines the key methodologies employed in evaluating scGPT and Geneformer.
The zero-shot evaluation paradigm is critical for assessing the fundamental biological understanding that models acquire during pretraining, without task-specific fine-tuning.
Gene network inference evaluates a model's ability to reconstruct biologically meaningful relationships between genes, reflecting its understanding of regulatory mechanisms.
Comprehensive frameworks like BioLLM provide standardized evaluation across diverse tasks to ensure fair model comparison.
The differential performance of scGPT and Geneformer stems from their distinct architectural choices and pretraining strategies, which shape how they process and interpret single-cell data.
Table 2: Model Architectures and Pretraining Approaches
| Feature | scGPT | Geneformer |
|---|---|---|
| Model Parameters | 50 million [1] | 40 million [1] |
| Pretraining Dataset Size | 33 million human cells [1] | 30 million single-cell transcriptomes [14] |
| Input Gene Selection | 1200 Highly Variable Genes (HVGs) [1] | 2048 ranked genes [1] |
| Value Representation | Value binning [1] | Gene ordering by expression level [1] |
| Positional Embedding | Not used [1] | Used [1] |
| Architecture Type | Transformer encoder with attention mask [1] | Transformer encoder [1] |
| Primary Pretraining Task | Iterative masked gene modeling with MSE loss [1] | Masked gene modeling with categorical gene ID prediction [1] |
The following diagram illustrates the relationship between model architectures and their resulting biological insights, highlighting how different pretraining objectives shape task-specific strengths:
Implementing scGPT or Geneformer in research workflows requires both computational resources and biological data of sufficient quality. The following table outlines key components of the experimental "toolkit" needed for effective model application.
Table 3: Essential Research Reagents and Resources
| Resource Category | Specific Resource | Function in Evaluation | Relevance to Model Performance |
|---|---|---|---|
| Reference Datasets | CELLxGENE [4] | Provides standardized, annotated single-cell data for pretraining and evaluation | Critical for model pretraining; dataset diversity impacts generalizability |
| Tabula Sapiens [4] | Multi-tissue atlas for evaluating cross-tissue performance | Tests model ability to handle biological complexity | |
| PBMC 12k [4] | Well-characterized immune cell dataset | Benchmark for immune cell profiling and batch integration | |
| Computational Tools | Harmony [4] | Batch effect correction algorithm | Baseline comparison for integration tasks |
| scVI [4] | Probabilistic generative model for single-cell data | Baseline for clustering and representation learning | |
| HVG Selection [4] | Feature selection method using highly variable genes | Simple baseline for evaluating embedding quality | |
| Evaluation Metrics | AvgBIO Score [4] | Measures cell type clustering performance | Quantifies biological relevance of embeddings |
| ASW (Average Silhouette Width) [4] | Evaluates clustering compactness and separation | Complementary metric for clustering quality | |
| scGraph-OntoRWR [1] | Novel metric measuring consistency with biological ontologies | Evaluates biological plausibility of learned relationships | |
| Hardware Resources | GPU (e.g., A100 [38]) | Accelerates model training and inference | Enables fine-tuning and large-scale application |
| Ascend910 NPUs [14] | Specialized AI training chips | Used for training large models like CellFM |
Based on the performance characteristics and experimental results, researchers can follow these evidence-based recommendations for implementing scGPT and Geneformer in different scenarios.
scGPT and Geneformer represent significant advances in single-cell computational biology, but their distinct architectural choices and training objectives lead to specialized strengths. scGPT demonstrates more robust performance across diverse cell-level tasks, particularly in batch integration scenarios involving complex biological and technical variations. In contrast, Geneformer excels at gene-level insights, showing stronger capabilities in gene network inference and function prediction. Researchers should select between these models based on their specific biological questions, prioritizing scGPT for atlas-level integration tasks and Geneformer for investigating gene regulatory mechanisms. As both models continue to evolve, ongoing benchmarking against traditional methods remains essential to ensure biological insights derive from meaningful computational advances rather than architectural complexity alone.
This guide provides a quantitative comparison of two prominent single-cell foundation models (scFMs), scGPT and Geneformer, focusing on their performance in bio-conservation, batch correction, and predictive accuracy. The evaluation is based on recent benchmark studies to inform researchers and drug development professionals in their model selection process.
This table summarizes model performance on key cell-level tasks, including cell type annotation (bio-conservation) and batch integration, as measured by established metrics. A higher score is better for all metrics. [1] [4]
| Task | Metric | scGPT | Geneformer | Top Performing Baseline |
|---|---|---|---|---|
| Cell Type Annotation(AvgBIO Score) | AvgBIO (Pancreas) | ~0.45 | ~0.35 | HVG (~0.65) |
| AvgBIO (Immune) | ~0.55 | ~0.40 | Harmony (~0.70) | |
| ASW (Tabula Sapiens) | ~0.75 | ~0.65 | scGPT (~0.75) | |
| Batch Integration(Batch Mixing Score) | iLISI (Pancreas) | ~0.60 | ~0.40 | HVG (~0.85) |
| iLISI (PBMC) | ~0.70 | ~0.45 | scVI (~0.80) | |
| PCR (Immune) | ~0.30 | ~0.15 | Harmony (~0.35) |
This table compares performance on gene function prediction and perturbation response modeling, which are critical for predictive accuracy and therapeutic discovery. [1] [14] [12]
| Task | Metric | scGPT | Geneformer | Notes |
|---|---|---|---|---|
| Gene Function Prediction | AUC (GO Term Prediction) | 0.72 | 0.75 | Geneformer benefits from effective pretraining on gene relationships [17]. |
| Perturbation Outcome Prediction | Pearson r (Transcriptome) | 0.25 (with fine-tuning) | 0.28 (with fine-tuning) | The Large Perturbation Model (LPM) significantly outperformed both (r > 0.45) [12]. |
| Zero-shot Gene Expression Prediction | Correlation | Poor (predicts median value) | Not Evaluated | scGPT showed limited ability without conditioning on cell embeddings [4] [15]. |
Objective: To assess the models' ability to generate cell embeddings that preserve biological cell types (bio-conservation) while removing non-biological technical variations (batch correction) [1] [4].
Workflow:
Zero-Shot Evaluation Workflow for Cell Embeddings
Objective: To benchmark the models' accuracy in predicting gene expression changes in response to genetic or chemical perturbations [12].
Workflow:
Workflow for Perturbation Prediction Benchmarking
This table lists the key datasets, metrics, and computational tools used in the benchmark studies, providing a practical resource for replicating or extending this research. [1] [4] [14]
| Category | Item | Function in Evaluation |
|---|---|---|
| Benchmark Datasets | Human Cell Atlas (e.g., from CellxGene) | Provides large-scale, diverse human scRNA-seq data for pre-training and benchmarking [1] [14]. |
| Pancreas Dataset | A standard benchmark with multiple batches and techniques for evaluating batch correction [4]. | |
| Perturbation Datasets (e.g., LINCS) | Contains genetic and chemical perturbation data for testing predictive accuracy [12]. | |
| Evaluation Metrics | AvgBIO / ASW | Quantifies how well an embedding preserves biological cell type identity (bio-conservation) [1] [4]. |
| iLISI / PCR | Quantifies how well technical batch effects have been removed (batch correction) [1] [4]. | |
| Pearson Correlation | Measures accuracy in predicting continuous outcomes, such as gene expression after perturbation [12]. | |
| Software & Models | BioLLM Framework | A unified framework that provides standardized APIs for integrating and evaluating different scFMs, streamlining model comparison [17]. |
| Harmony / scVI | Established baseline methods for data integration against which new foundation models are compared [1] [4]. | |
| HVG Selection | A simple, yet strong baseline for feature selection that often competes with or outperforms complex foundation models in zero-shot tasks [4] [15]. |
In the rapidly evolving field of single-cell transcriptomics, foundation models like scGPT and Geneformer promise to revolutionize biological discovery. However, comprehensive benchmarking reveals a critical insight: no single model consistently outperforms all others across diverse tasks. Performance is highly dependent on the specific application, with scGPT generally demonstrating stronger all-around capabilities, particularly in cell-level tasks, while Geneformer shows strengths in certain gene-level analyses. This guide provides an objective comparison of their performance, supported by experimental data, to inform researchers and drug development professionals in selecting the appropriate tool for their specific needs.
Single-cell RNA sequencing (scRNA-seq) provides unprecedented insights into cellular heterogeneity, yet analyzing this data presents challenges due to its high dimensionality, sparsity, and technical noise. Single-cell foundation models (scFMs), pre-trained on millions of cells, aim to learn universal biological representations that can be adapted to various downstream tasks. Two prominent models, scGPT and Geneformer, have emerged with different architectural approaches and training methodologies.
scGPT employs a transformer architecture with a value categorization strategy, binning gene expression values into discrete buckets. Pre-trained on over 33 million human cells, it uses an attention mask mechanism for autoregressive prediction and is designed for diverse tasks including cell-type annotation, batch integration, and gene network inference [14] [1] [38].
Geneformer utilizes a gene-ranking approach, representing cells as sequences of genes ordered by expression levels. Pre-trained on approximately 30 million single-cell transcriptomes, it uses a masked language model objective where the model predicts the identity of masked genes based on context [14] [1].
Both models follow a "pre-train then fine-tune" paradigm, but their zero-shot performance—using pre-trained models without task-specific fine-tuning—is critical for discovery settings where labels are unknown [4].
Rigorous evaluations of scGPT and Geneformer reveal a task-dependent performance landscape. The following comparative analysis synthesizes findings from multiple benchmarking studies to provide a holistic view of their capabilities.
Cell type clustering is a fundamental task in single-cell analysis where models must group cells by biological function rather than technical batch effects. In zero-shot settings, where models are applied without fine-tuning, both scGPT and Geneformer show significant limitations.
Table 1: Zero-Shot Cell Type Clustering Performance (AvgBIO Score)
| Model | PBMC (12k) | Tabula Sapiens | Pancreas | Immune Dataset |
|---|---|---|---|---|
| scGPT | 0.65 | 0.48 | 0.42 | 0.45 |
| Geneformer | 0.38 | 0.31 | 0.35 | 0.33 |
| scVI | 0.63 | 0.59 | 0.58 | 0.62 |
| Harmony | 0.61 | 0.55 | 0.56 | 0.58 |
| HVG | 0.68 | 0.62 | 0.61 | 0.64 |
Evaluation across five datasets shows that both foundation models are outperformed by simpler methods like Highly Variable Genes (HVG), scVI, and Harmony. Geneformer particularly struggles, with performance substantially below other methods. scGPT shows more competitive performance on the PBMC dataset but remains inferior to established baselines on others [4].
Batch integration removes technical variations between datasets while preserving biological signals. This is crucial for combining data from multiple sources.
Table 2: Batch Integration Performance (Batch Mixing Score)
| Model | Pancreas | PBMC | Tabula Sapiens | Immune Dataset |
|---|---|---|---|---|
| scGPT | 0.52 | 0.61 | 0.72 | 0.69 |
| Geneformer | 0.31 | 0.35 | 0.38 | 0.41 |
| scVI | 0.71 | 0.75 | 0.65 | 0.58 |
| Harmony | 0.69 | 0.72 | 0.55 | 0.73 |
| HVG | 0.76 | 0.78 | 0.74 | 0.75 |
In batch integration, Geneformer consistently ranks last across all datasets, often increasing batch effects compared to raw data. scGPT shows intermediate performance, outperforming scVI and Harmony on complex datasets with biological batch effects (Tabula Sapiens and Immune) but underperforming on datasets with purely technical variation [4].
Predicting transcriptional responses to genetic perturbations is a key application for therapeutic development. Surprisingly, foundation models show limited capability in this domain.
Table 3: Perturbation Prediction Performance (L2 Distance for Top 1000 Genes)
| Model | Double Perturbation (Norman et al.) | Unseen Single Perturbation (Replogle et al.) |
|---|---|---|
| scGPT | 6.21 | 5.89 |
| Geneformer* | 6.85 | 6.92 |
| scFoundation | 6.45 | N/A |
| Additive Baseline | 5.72 | 5.65 |
| No Change Baseline | 6.15 | 5.94 |
Note: Geneformer and other models not designed for perturbation prediction were repurposed with a linear decoder [24].
None of the deep learning models outperformed deliberately simple baselines, including an additive model that sums individual perturbation effects. This indicates current foundation models have limited ability to generalize to perturbation prediction despite significant computational resources required for fine-tuning [24].
A comprehensive 2025 benchmark evaluating six scFMs across two gene-level and four cell-level tasks provides holistic rankings:
Table 4: Overall Model Rankings by Task Type
| Model | Cell-Level Tasks | Gene-Level Tasks | Overall Ranking |
|---|---|---|---|
| scGPT | 1 | 2 | 1 |
| Geneformer | 4 | 1 | 3 |
| scFoundation | 3 | 3 | 2 |
| UCE | 2 | 4 | 4 |
| scBERT | 5 | 5 | 5 |
scGPT demonstrates robust performance across all tasks, particularly excelling in cell-level applications. Geneformer shows stronger performance in gene-level tasks, benefiting from its effective pretraining strategy, but lags in cell-level applications [1] [17].
To ensure reproducible evaluations, benchmarking studies follow standardized protocols across tasks. Below are the methodologies for key experiments cited in this guide.
Objective: Evaluate model-generated cell embeddings' ability to separate known cell types without task-specific training.
Dataset Preparation:
Embedding Generation:
Evaluation Metrics:
Statistical Analysis:
Objective: Quantify model's ability to remove technical batch effects while preserving biological variation.
Dataset Selection:
Integration Workflow:
Evaluation Framework:
Quantitative Ranking:
Objective: Assess model capability to predict gene expression changes after genetic perturbations.
Data Sources:
Experimental Setup:
Model Adaptation:
Evaluation Metrics:
The following diagram illustrates the standardized evaluation workflow used in benchmarking studies to ensure fair comparison across models:
Diagram Title: scFM Evaluation Workflow
The following diagram illustrates the complex relationship between model characteristics, task types, and performance outcomes based on benchmarking results:
Diagram Title: Model-Task Performance Relationships
To implement and evaluate single-cell foundation models effectively, researchers require specific computational tools and resources. The following table details key components of the experimental ecosystem:
Table 5: Essential Research Reagents for scFM Evaluation
| Resource Category | Specific Tools | Function & Purpose |
|---|---|---|
| Benchmarking Datasets | Norman et al. perturbation data, Tabula Sapiens, Pancreas datasets | Provide standardized biological contexts with high-quality ground truth labels for fair model comparison |
| Evaluation Metrics | AvgBIO score, ASW, Batch mixing scores, L2 distance | Quantitatively measure model performance across different task dimensions using established statistical measures |
| Baseline Methods | HVG selection, scVI, Harmony, Additive model | Serve as performance baselines to contextualize foundation model results and prevent exaggerated claims |
| Computational Frameworks | BioLLM, scib-metrics, Census API | Provide standardized interfaces for model access, evaluation, and comparison across heterogeneous architectures |
| Visualization Tools | UMAP, t-SNE, Graphviz | Enable qualitative assessment of embeddings and experimental workflows through dimensionality reduction and diagramming |
These standardized resources enable reproducible benchmarking and prevent evaluation artifacts that might favor specific model architectures [4] [21] [24].
The comprehensive benchmarking data reveals that neither scGPT nor Geneformer universally dominates across all applications. Instead, model selection should be guided by specific research needs:
For cell-level tasks and batch integration: scGPT generally provides more robust performance, particularly in zero-shot settings where immediate application without fine-tuning is required [4] [17].
For gene-level functional analysis: Geneformer demonstrates strengths, benefiting from its pretraining approach that captures gene relationships effectively [1] [17].
For perturbation prediction: Surprisingly, simple linear baselines currently outperform both foundation models, suggesting caution when applying these models to therapeutic development applications [24].
For exploratory analysis with unlabeled data: scGPT's zero-shot embeddings provide a reasonable starting point, but practitioners should maintain simpler baselines like HVG selection as competitive alternatives [4] [38].
The absence of a single universal winner underscores the importance of task-specific model selection. Researchers should consider dataset characteristics, computational resources, and specific biological questions when choosing between scGPT, Geneformer, or simpler alternative methods. As the field evolves, continued rigorous benchmarking remains essential to translate model capabilities into genuine biological insights and therapeutic advances.
The benchmarking evidence clearly indicates that while scGPT and Geneformer represent significant advancements, neither consistently outperforms well-established, simpler methods like PCA, scVI, or HVG selection in zero-shot settings. scGPT often demonstrates more robust overall performance across diverse tasks, whereas Geneformer shows specific strengths in gene-level analyses. The choice between them should be guided by the specific biological task, dataset characteristics, and available computational resources. For the field to progress, future development must prioritize rigorous zero-shot evaluation, improved pretraining objectives that capture deeper biological relationships, and the creation of standardized frameworks like BioLLM for fair comparison. The ultimate goal remains the development of models that genuinely learn and generalize biological principles to accelerate drug discovery and clinical translation.